title: What do we gain from the sixth coronary heart disease drug?
authors.forename: Rebecca N
authors.initials: RN
authors.lastname: Warburton
mesh_terms: D003327:Coronary Disease / Q000188:drug therapy* / Q000191:economics; D003362:Cost-Benefit Analysis; D006801:Humans; D017410:Practice Guidelines as Topic; D019057:Quality-Adjusted Life Years; D012308:Risk Management / Q000191:economics